Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.
The human glucocerebrosidase (GC) gene has been transferred efficiently into spleen colony-forming unit (CFU-S) multipotential hematopoietic progenitor cells, and production of human GC RNA and protein has been achieved in transduced CFU-S colonies. High-titer retroviral vectors containing the human GC cDNA were constructed. Mouse bone marrow cells were stimulated with hematopoietic growth factors, infected by coculture with producer cells, and injected into lethally irradiated animals. Four vectors were compared with respect to gene-transfer efficiency into CFU-S progenitors. One vector (G vector) required high concentrations of interleukins 3 and 6 during stimulation and coculture for efficient transduction of CFU-S progenitors. The remaining three vectors (NTG, GTN, and GI vectors) transduced these progenitors at infection frequencies approaching 100% using low concentrations of hematopoietic growth factors to stimulate cell division prior to and during the infection. Vectors using the viral long terminal repeat enhancer/promoter to drive the human GC cDNA produced high levels of human GC RNA in the progeny of CFU-S progenitors after gene transfer. When an internal herpes simplex thymidine kinase promoter assisted by a mutant polyoma enhancer was used to drive the human GC cDNA (NTG vector), little or no human GC RNA was detected in transduced CFU-S colonies. All three vectors producing human GC RNA in CFU-S colonies can generate human GC as detected by immunochemical analysis of CFU-S colonies. NTG vector-infected bone marrow cells were transplanted into W/Wv recipients to generate long-term reconstituted mice. The capacity of the viral long terminal repeat and the internal thymidine kinase promoter to direct synthesis of RNA in transduced bone marrow and spleen cells 5 months after bone marrow transplantation reflected the performance of these promoters in NTG-transduced CFU-S colonies.
Correll
P H
PH
Molecular and Medical Genetics Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.
Fink
J K
JK
Brady
R O
RO
Perry
L K
LK
Karlsson
S
S
D000818:Animals; D015152:Blotting, Northern; D015139:Blotting, Southern; D016026:Bone Marrow Transplantation; D004259:DNA-Directed DNA Polymerase; D005784:Gene Amplification; D015870:Gene Expression; D005796:Genes; D005822:Genetic Vectors; D005959:Glucosidases / Q000235:genetics*; D005962:Glucosylceramidase / Q000096:biosynthesis / Q000235:genetics*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000201:enzymology; D006801:Humans; D051379:Mice; D012190:Retroviridae / Q000235:genetics; D014158:Transcription, Genetic; D014162:Transfection
D004259:DNA-Directed DNA Polymerase; D005959:Glucosidases; D005962:Glucosylceramidase